chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BODY ACHES; TINGLING IN LEFT CHEEK; FATIGUE; This spontaneous report received from a patient concerned a 27 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 to right deltoid for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced tingling in left cheek. On APR-2021, the subject experienced fatigue. On 02-APR-2021, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, and the outcome of fatigue and tingling in left cheek was not reported. This report was non-serious.
Oxygen desaturation with feeds as well as persistent apneas and irritability. Baby was admitted for sepsis work up including spinal tap and head ultrasound on 1/10/16. She required nasal cannula treatment. She was placed on antibiotics and antivirals. Due to the irritability, MRI has been ordered and antibiotics are to be continued for 7 day course.
1 week later I came down with COVID-19. I know they claim that you cannot catch covid from the vaccine but I had no other exposures so I think you should look into the data with it more. The nurse who gave me my second shot had a few other employees who caught it after the first shot.
Arm soreness; Headache; Extreme fatigue; Dizziness; Bleeding from both nostrils; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6204), via an unspecified route of administration in left arm on 03Mar2021 at 14:15 (at the age of 64-years-old), as a single dose for COVID-19 Immunisation. The patient's medical history included 2 ischemic strokes on May2018. The patient did not had any allergies to medications, food, or other products. Prior to vaccination, the patient was not been diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patients concomitant medications were not reported. The patient experienced dizziness, 10 minutes after first shot, arm soreness for 3 days, headache from day 1 to 3 and 6 to 7, extreme fatigue from day 1 to 2 and 6 to 7 on 03Mar2021 at 14:30. The patient experienced bleeding from both nostrils (two weeks after first injection) on an unknown date in Mar2021 from day 3 until present. Bleeding started as dark bloody crust inside nose, then turned to red blood every time the nose was blown, from both nostrils. No therapeutic measures were taken for the events. At the time of report, the outcome of the events bleeding from both nostrils, arm soreness, headache, dizziness and extreme fatigue was not recovered.   No follow-up attempts are needed. No further information is expected.
Patient received dose on 2/1.  On 2/10, patient awoke with itching and redness (2" diameter) on the right arm.  Patient self managed with Cortizone 10.  Redness improved and almost gone by 2/16.
pt devel erythema & peripheral edema of face 5 hrs p/vax; MD observed that pt had an insect bite on shoulder; baseline t98.8 & p/vax 99.3; no inject site react; rx DPH-recovered; @ time of immun on 2 wk course of amoxicillin for ear infect;
This spontaneous report was received from a registered nurse and refers to a 50-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 02-DEC-2016, the patient was inadvertently vaccinated with PROQUAD (lot # M012986, expiration date was not provided) (dose and route of administration were not provided). The patient was scheduled to receive M-M-R II. No adverse effects were reported. Product quality complaint was not involved. This is one of the two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA008788.
Dose 1 given 2/5/2021 Moderna lot # 016M20A  Patient died of Covid 19 pneumonia, respiratory failure
Headache, Myalgia, Syncope, multiple episodes of near syncope within minutes to an hour after the injection, did not seek treatment Narrative:
patient received vaccine in the morning around 10-11 am, patient started to have difficulty in swallowing around 2-3 pm and was seen but a provider, epi pen was administered, EMS was notified, patient declined EMS services, patient reported improvement after the administration of EPI.
2 year old presented for follow up 24 hours after influenza vaccine administered right deltoid. Noted to have scattered erythematous macular blanchable rash approximately 8-10 hours after vaccine. No recent changes in soap/detergent/shampoo nor foods. No known recent illness. No lip/tongue swelling, vomiting nor breathing difficulties. Family treated with benadryl at home for itching. When seen in office rash erythematous blanchable and raised suggestive of potential type III hypersentivity reaction most prominent on abdomen with areas of confluence.  Plan for symptomatic treatment with oral antihistamine for itching (Benadryl/Zyrtec) and taper of oral steroid.
4 days after receiving vaccine every joint in my body flared up to the extent that walking/any range of motion was difficult. Significant swelling in knees and ankles/feet. Excruciating pain in all joints, difficulty lifting left leg to get into shower or car. Eye inflammation.
rash reported 26NOV93 1st noticed inc over next few days; shot recvd 15NOV93 in the evening, nauseated, malaise as of 29NOV93; feeling tired, loss of hunger;
Patient is a 10 year old female who has completed a 3 minutes-minute observation period with the following signs and symptoms of an adverse reaction: sensation of throat swelling or throat closure. Pfizer-BioNTech COVID-19 vaccine #1 in series administered.  Action(s) taken: Another drug administered - Benadryl 25 mg  Allergy to COVID-19 vaccine documented in Allergies activity: No, will sent message to PCP for Advise   Patient mom advised to discuss second dose considerations with a clinician  RN  {IMPORTANT:  If patient has any one of the following:   sensation of throat swelling or throat closing in  Consulted Dr  Administer Benadryl 25 mg by mouth as ordered    Associate order with diagnosis code, VACCINATION FOR SARS-COV-2 [659210]. If patient is observed for 45 minutes or longer:
States he developed low grade fever of 99.5-100.0 which continued for 4 days. Also states his skin hurt. Then on 12/18/09 he developed a rash that started on his hands. Then noticed itching, burning and swelling of hands. Then noticed he had a splotchy rash on chest, between knees. Took Benadryl 12/19/09 and then started steroid dose pack on 12/20/09, which has helped reduce swelling of hands.
Administered after possible temperature excursion; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Oct-2021 and was forwarded to Moderna on 01-Oct-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Administered after possible temperature excursion) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced PRODUCT STORAGE ERROR (Administered after possible temperature excursion). On 09-Sep-2021, PRODUCT STORAGE ERROR (Administered after possible temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.
nervous; nosebleed/ nose began to bleed out of nowhere; This is a spontaneous report from a Pfizer sponsored program.    A contactable consumer (patient) reported that a 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown) via an unspecified route of administration on 16Apr2021 (unknown age at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had her 1st dose on 16Apr2021 and she felt alright. However, on the day of reporting morning (19Apr2021) while doing the laundry she had a nosebleed and she is concerned on what she will do next and whether it is related to the vaccine. She also reported that she was sitting in her car when her nose began to bleed out of nowhere. She states that she is nervous because she doesn't normally experience nosebleeds unless she is blowing her nose really hard. She asked if she should be concerned and if this is a common reaction. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 08-DEC-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L028666; expiry date 04-NOV-2016, (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Patient stated she had more than a sore arm on the day of the immunization. She experienced nausea and dizziness as well. On Sunday, while showing her husband her arm, there was a spot on shoulder with a distinct red line going towards her back.
Runny nose-1.5 days Sore throat-1.5 days Constant coughing severe nonstop-4 days  Limited appetite-5 days Sore arm at injection site-2 days
Left upper eyelid swelling and mild reddish purple skin coloration ~3 hours after receiving vaccine. No vision changes or other associated symptoms. Took one 25mg dose benadryl which reduced symptoms. Symptoms resolved over the course of the following day without further issue.  Did not have problem with any of the earlier Pfizer vaccine doses.
Mother of PT stated. Daughter was very fussy, took a nap, felt warm. Woke up from her nap at 10:00 AM, and began nursing from mother. Then she started having a seizer. PT was taken to local ER with a fever of 102.3F. Mother says no fevers since the 01/22/2017.
Arm soreness; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD exacerbation, Allergy to antibiotic (Azithromycin (Z pack)) and Drug allergy (Shingles medicine). Concomitant products included PREDNISONE for COPD, ETOFYLLINE, THEOPHYLLINE (DERICIP), AMLODIPINE, FUROSEMIDE, POTASSIUM, LOSARTAN, METOPROLOL, ALPRAZOLAM and MONTELUKAST for an unknown indication.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Tired). At the time of the report, PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Tired) had resolved.            Treatment information was not provided.  Patient was at the End of Stage life received second dose of Moderna COVID-19 vaccine.   Patient had COPD exacerbation and takes prednisone daily.   Following the vaccination patients was tired, had sore arm and events were resolved in few days.
post vaccine: sudden onset of dizziness, vertigo sensation with nausea, witnessed near-syncopal event, "everything going black in color" per patient, skin clammy and pale/warm and diaphoretic, spinning sensation, bradycardia and mild hypotension with abnormal cardiac rhythm- EMS called by on-site paramedic at 12:55 12:50 HR 42, BP 90/64, SaO2 97, Resp 18, sinus bradycardia. GCS=15 1306= HR 105, BP 102/64, SaO2 98, Resp 16, Sinus tachycardia, GCS=15 13:16 blood glucose 175 mg/dL  No medications required
Pt seizured minutes after last vaccine given, became pale. Pt laid down, juice given with crackers.
Patient waited at the pharmacy for 15 minutes with no problems at all.  Patient's wife called back 2 hours later around 12:43pm  and said the patient noticed a metallic taste in his mouth about 15 minutes after his vaccination.  No other adverse issues.  I called patient back around 2:15pm and he was resting with no other issues per consult with wife.    Advised patient's wife to seek immediate medical attention if any other adverse events developed (rash, swelling, itching, tickle in throat any difficulty breathing,  facial drooping or anything out of the ordinary).    Also advised patients wife to contact us if there were any changes or if the patient had to seek medical treatment.
Pt received 4th vax on 01/05/1999. It was reported that in 02/1995 the pt received full series of hepatitis B vax. Subsequently, the pt's hepatitis B titer was below 6 IU/mL. Sometime after the booster dose, the pt developed enlarged cervical and axillary lymph nodes. The physician was 'not certain of the relationship to the vax due to the pt's history of lymphoma. The physician will be taking biopsies of the lymph nodes.' Additional information has been requested.
Red, swollen, painful right arm along with flu like symptoms of chills, sweating, body aches. Presented to ER to address the symptoms.
Unable to rotate left arm (vaccinated arm). Injection site also slightly swollen. Tingly finger (left arm).
had my antibodies tested yesterday and I don't have any; This is a spontaneous report from a contactable physician (patient). A male patient of an unspecified age received second dose of BNT162B2 (Lot/batch number and expiry date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported It was reported that the patient received the 2nd Pfizer covid vaccine 15 days ago, he had his antibodies tested yesterday and he doesn't have any. This is not related to efficacy, it's more related to not developing antibodies. It's not apart of your clinical trial study, this is more related to the developing of antibodies. He asked if there any information related to not developing antibodies. The patient underwent lab tests and procedures which included Covid-19 antibody test: negative (don't have any) on an unknown date. The outcome of the event was unknown.  Information about batch/lot number has been requested.
Information has been received from a health professional concerning a 51 year old female with seasonal allergies, asthma, allergies to propoxyphene hydrochloride (DARVON) and tetanus and high cholesterol who on 02-APR-2005 was vaccinated with a first 0.5ml dose of varicella virus vaccine live. Concomitant therapy included fexofenadine hydrochloride (ALLEGRA), rosiglitazone maleate (AVANDIA), glimepiride (AMARYL), atorvastatin calcium (LIPITOR), estrogens, conjugated (PREMARIN), montelukast sodium, fluoxetine HCl (PRAZAC), ramipril (ALTACE), lorazepam (ATIVAN), metoprolol succinate (TOPROL XL TABLETS) guaifenesin (MUCINEX) and aspirin. On approximately 09-APR-2005, a week after vaccination, the patient experienced a generalized rash with pustules, blisters and oozing. The patient's condition resolved in three weeks, approximately 30-APR-2005. Treatment was unknown. It was also noted that a titer was negative. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
I had normal arm pain, tender to the touch, redness and itching. Within 24 hours I developed heart palpitations that were continual 24/7. After probably a week I started getting tightness in my chest. The third week I had a lump in my throat. I went to the doctor that Friday with concerns. She took my blood pressure and pulse and said it was just anxiety. She did an EKG and blood work because I said it was not anxiety because I did not have anything to be anxious. She said it was just anxiety and gave me anxiety medications. I took that for 3-4 days. That did not help and I could not drive. I message her that it was not helping and I asked what could we do. She referred me to a cardiologist. She prescribed a beta blocker. That helped somewhat and it would decrease how far my chest was pounding for about an hour. I went to see the cardiologist yesterday and he said I have isolated myocarditis. He has me on halter monitor until Friday. I went this morning for blood work.  I am also going for a cardiac MRI and EKG at the end of October. I was actually on the way to urgent care because originally the cardiologist said they could not see me until October 21st but I could not wait because my symptoms were getting worse until they called me and said they could see me earlier.
Initially after the second vaccine he had typical myalgias/arthralgias, especially shoulder/neck. On 3/19 he got acutely worse with severe pain both shoulders/wrists/hands. He came to ER 3/24 with symmetric inflammatory arthritis involving shoulders/wrists/hands and edema of the hands-pitting edema on dorsum of right hand. He was in such pain that he couldn't take off his shirt without assistance, couldn't bend the wrists, couldn't make a fist.   Clinically, this looked like RSP3PE and resolved within 24 hours on prednisone 20 mg bid which is tapered down today.    Patient returned to the ER today 3/24 with nausea/vomiting and that is currently being worked up. If it appears that this has anything to do with the vaccine, I will file a second report with the new symptoms.
missed his 2nd dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed his 2nd dose of Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed his 2nd dose of Moderna vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed his 2nd dose of Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated "No" when asked about if any treatment received or is on any concomitant medications.
Pt. received the vaccine as the last part of the wellness exam, and left the office within minutes of receiving it. Pt. felt a headache in the elevator on the way down to the ground floor, as we exited the building and headed to the car he lost both the majority of his vision and his hearing ( the doctors called this a "white out"), I grabbed his arm and pulled him pack into the medical facility where he then was quickly having trouble walking and standing. We said we needed the doctor. Pt was still having trouble seeing and hearing and was now feeling nauseous, he said he was going to be sick immediately and we were able to make it to a garbage can where he did vomit. During this time, someone found him a wheelchair as he was not able to stand. Three people on the ground floor helped us with a wheelchair, wet and dry towels and a call to Dr who told us to head to the Emergency Room ASAP. WHich we did.
Knot underneath the skin that changed to an erythematous, indurated plaque on the skin, painful to touch.
During the night of 1/25/2021, I developed fever, chills, and aches. On the morning of 1/26/21, my fever was 102 degrees with intense chills and aches. On 1/27/21, my fever was 101 degrees. My fever broke by 1/28/21. I had little to no appetite from 1/26/21 through 1/29/21. No diarrhea or vomiting symptoms. Left arm pain/discomfort throughout intensifying on evening of 1/25/21 ending on 1/29/21.
On the 8th day following receipt of vaccine I noticed a non-itchy "hive-like" rash at the injection site.  On the 9th day the redness increased.  Prior to this, on the day I received the vaccine,  I experienced soreness for 24 hours at the site of vaccine and a bit of nausea several hours later.
Tingling and numbing sensation in face around mouth and chin.; Tingling and numbing sensation in face around mouth and chin.; This is a spontaneous report from a non-contactable consumer (patient). A 27-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: not reported), via an unspecified route of administration in the left arm on 11Feb2021 at 02:30 (at the age of 27-year-old) as single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported. The most recent COVID-19 vaccine was administered in workplace clinic. The patient did not have any known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, it was unknown if patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced tingling and numbing sensation in face around mouth and chin on 25Feb2021. The patient did not receive any treatment. The clinical outcome for the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Patient states that she is experiencing numbness and tingling down her arm, the same arm that she received the vaccination in.
Patient was a 17 year old female that presented to the pharmacy for her senior high school vaccinations. Patient appeared to be in good health and marked that she had prior doses of meningitis and HPV vaccinations. She reported no prior incidents with vaccinations, no allergies or medical conditions. Patient received the Fluarix and Menactra in her left deltoid one inch apart from one another as well as the Gardasil 9 and Trumenba in her right arm one inch apart from one another. Left arm vaccinations were administered first, followed by the right arm. Patient was tolerating all injections well until at the last injection (Trumenba) the patient fainted in the seated position. The pharmacist caught the patient and supported her head and neck. The patient maintained vitals but was unconscious for a total of approximately 10 minutes. Ammonia inhalant smelling salts were used to rouse the patient and EMS was summoned.
in addition to the painful arm, an hour after my nose started running, burning watery eyes, followed by headache, fever, chills, nausea, fatigue, This lasted for four days. Wednesday 5/19 the arm that was injected blew up to  a large hard bump with an itchy rash. The large swollen  hard itchy rash bump is still there on Friday 5/21.
Lots of small to medium bruises on the back side of both of my legs that randomly showed up after 4 days.
Patient experienced moderate to severe itchiness, hives and flare-ups a day after the 2nd vaccine.  Duration was 2-3 weeks and now is experiencing mild to moderate symptoms.  Patient took benadryl 1-2 times daily a week and a half later but has stopped benadryl because it hasn't been effective